Elevance Health Aktie
| 348,16USD | 1,98USD | 0,57% |
WKN DE: A12FMV / ISIN: US0367521038
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 98 200 | 102 300 | 104 900 | 104 200 | 97 100 |
| Umsatz pro Mitarbeiter in Mio. EUR | 1,41 | 1,53 | 1,63 | 1,70 | 2,05 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 51 122 | 55 617 | 60 029 | 58 942 | 63 001 |
| Summe Anlagevermögen | 46 338 | 47 155 | 48 899 | 57 947 | 58 493 |
| Summe Aktiva | 97 460 | 102 772 | 108 928 | 116 889 | 121 494 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 61 332 | 66 378 | 69 523 | 75 463 | 77 468 |
| Summe Eigenkapital | 36 128 | 36 394 | 39 405 | 41 426 | 44 026 |
| Summe Passiva | 97 460 | 102 772 | 108 928 | 116 889 | 121 494 |
Adresse
| 220 Virginia Avenue, 46204 Indianapolis | |
| Telefon | +1 (833) 401-1577 |
| Internet | http://www.elevancehealth.com |
Management
|
Amy L. Schulman
Independent Director |
|
Antonio Fabio Neri
Independent Director |
|
Bahija Jallal
Independent Director |
|
Chris Rigg
Senior VP & CFO-Commercial & Specialty Business |
|
Deanna Dawnette Strable-Soethout
Independent Director |
|
Erin Wessling
Chief Legal Officer |
|
Felicia Farr Norwood
President-Government Health Benefits & EVP |
|
Gail Koziara Boudreaux
President, Chief Executive Officer & Director |
|
Hakon Mattson
Chief Sustainability Officer |
|
Jill A. Becher
Vice President-Planning & Execution |
|
Kathleen S. Kiefer
Secretary & Chief Governance Officer |
|
Kyle Weber
Chief Strategy Officer |
|
Lewis Hay
Independent Director |
|
Mark B. Kaye
Chief Financial Officer & Executive Vice President |
|
Morgan Kendrick
President-Commercial Health Benefits & EVP |
|
Nathan Rich
Vice President-Investor Relations |
|
Peter David Haytaian
Executive VP, President-Carelon & CarelonRX |
|
R. Kerry Clark
Independent Director |
|
Rachel Stuve
Sr. Director Data Science & AI |
|
Ramiro G. Peru
Chairman |
|
Ratnakar Lavu
Chief Digital & Information Officer & Executive VP |
|
Robert L. Dixon
Independent Director |
|
Ronald William Penczek
Chief Accounting Officer & Controller |
|
Ryan Craig
Chief Human Resources Office |
|
Ryan M. Schneider
Independent Director |
|
Scott Towers
President-Dental Business |
|
Shantanu Agrawal
Chief Health Officer |
|
Steven H. Collis
Independent Director |
|
Susan D. DeVore
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.